Expora Therapeutics
PrivateLast Round
Grant
Dec 1, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Expora Therapeutics is a biotechnology company that develops oral bacterial extracellular vesicle disease-modifying immunotherapies for gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Expora Therapeutics Comparables
Compare Expora Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MD Healthcare | 68% | |
| Delonix Bioworks | 63% | |
| Evox Therapeutics | 61% | |
Expora Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2025 | ||||
| Grant | Feb 1, 2025 |
Expora Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University System of Maryland Launch Fund | Grant |
| TEDCO | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
Received funding from the University System of Maryland Launch Fund.
Expora Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Expora Therapeutics's valuation, stock price, and market status.